Status:
RECRUITING
SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study
Lead Sponsor:
Helio Tedesco Silva Junior
Collaborating Sponsors:
Hospital do Rim e Hipertensão
Conditions:
SARS-CoV-2 Infection
Kidney Transplant Infection
Eligibility:
All Genders
Brief Summary
COVID-19 is the pandemic disease caused by the SARS-CoV-2 coronavirus. It is a highly contagious viral disease, the condition of which main clinical symptoms are characterized by fever and respiratory...
Detailed Description
COVID-19 is the pandemic disease caused by the SARS-CoV-2 coronavirus. It is a highly contagious viral disease, the condition of which main clinical symptoms are characterized by fever and respiratory...
Eligibility Criteria
Inclusion
- Kidney transplant recipients, which may be multi-organ recipients, transplanted in any follow-up period;
- Positive diagnostic test for COVID-19 (detection of viral load, test for detection of antigens or tests for detection of antibodies);
- Outpatient or hospital management;
- Adults and children.
Exclusion
- \-
Key Trial Info
Start Date :
May 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 2 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04494776
Start Date
May 21 2020
End Date
April 2 2025
Last Update
November 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital do Rim
São Paulo, Aão Paulo, Brazil, 04038-002